Clinical Management of Stroke Flashcards
Describe the current main therapeutic options for ischaemic stroke including intravenous and interventional recanalisation therapy Identify additional therapies established for stroke Discuss the evolving options for management of intracerebral haemorrhage
How many new strokes occur in the UK every year?
150,000
Define acute stroke
An acute-onset focal neurological deficit caused by vascular disorder
What percentage of strokes are caused by ischaemia?
80%
What percentage of strokes are caused by cerebral haemorrhage?
10-15%
What percentage of strokes are caused by subarachnoid haemorrhage?
5%
What percentage of strokes are caused by sinus and venous thrombosis?
2%
Which area of ischaemia is targeted in acute ischaemic stroke intervention?
The ischaemic penumbra - the area around the core ischaemia which receieves some blood from the blocked vessel but some blood from other vessels
Why is a CT scan necessary in all strokes?
To exclude haemorrhage
Within what time after onset can IV thrombolysis or mechanical thrombectomy be offered?
4 hours
Describe IV thrombolysis
An IV bolus of 0.9mg/kg recombinant tissue plasminogen activator over 60 minutes
The modified Rankin scale for stroke outcome goes from 0-6. What is a 2?
Independent with slight disability - can self-care but unable to perform all previous activities
The modified Rankin scale for stroke outcome goes from 0-6. What is a 4?
Needs help to mobilise and to attend to own bodily needs
What percentage of stroke patients will have their blood vessels unblock (recanalise) spontaneously?
24.1%
In what percentage of patients is vessel unblocking successful with IV rTPA and mechanical thrombectomy respectively?
IV rTPA: 46.2%
Mechanical thrombectomy: 83.6%
Describe the process of mechanical thrombectomy
A catheter is inserted into the vessel, then a stent is unfolded. The thrombus goes into the holes of the stent, which is then retracted to remove the thrombus
Give a piece of evidence for using mechanical thrombectomy after the 4h time window
1) DEFUSE-3 trial - thrombectomy in the 6-16h time window increased likelihood of a functionally independent outcome 3x
2) DAWN trial - mechanical thrombectomy in the 6-24h time window is effective in certain carefully selected patients
Define basilar artery thrombosis
Atherothrombotic or embolic occlusion of the basilar artery, which supplies the brainstem
State the typical symptoms of basilar artery thrombosis
Fluctuating vertigo and loss of consciousness
State the prognosis after basilar artery thrombosis
50-90% mortality with severe morbidity including locked-in syndrome
Describe the symptom progression of a space-occupying middle cerebral artery infarct
Severe neurological deficit, with oedema leading to midline shift and brainstem compression, eventually inhibiting cardiorespiratory signals
What is the standard treatment for a space-occupying middle cerebral artery infarct?
Hemicraniectomy
Give a piece of evidence supporting the use of hemicraniectomy for space-occupying middle cerebral artery infarcts
DESIRE trial - hemicraniectomy reduces mortality, increases the number of patients with lower-level disability, and produces no increase in patients in a vegetative state
Describe how a stroke unit reduces morbidity and mortality (Cochrane review, 2004)
Monitor patients with acute stroke in the sub-stable phase, carry out immediate diagnostic workup for cause, immediate specific therapy and secondary prevention (e.g. heparin), continuous vital sign monitoring
What is the 1 year mortality of intracerebral haemorrhage?
37-47%
What is the most common cause of non-traumatic intracerebral haemorrhage?
Hypertensive arteriolopathy
State 4 causes of intracerebral haemorrhage other than hypertensive arteriolopathy
Trauma, anticoagulants, cerebral amyloid angiopathy, tumours, vascular malformations
How are cerebral amyloid angiopathy haemorrhages different to those caused by hypertensive arteriolopathy?
Hypertensive haemorrhages are more likely to be deep, CAA haemorrhages more likely to be superficial
State, in order of commonality, the sites for intracerebral haemorrhages
Lobar, basal ganglia and thalamus, cerebellum and brainstem
Name the sign on MRI that predicts haematoma enlargement
The spot sign
Describe the results of trials into using recombinant factor VIIa to treat intracerebral haemorrhage
Reduction in haematoma volume but no improvement in death or disability rates at 90 days. Increased risk of thromboembolic events
Describe the results of the UK TICH-2 trial (Sprigg et al, 2018) into intracerebral haemorrhage
Tranexamic acid had no impact on intracerebral haemorrhage disability or death
State 3 factors associated with haematoma growth
Deep location, high systolic blood pressure, high INR level on first measurement
State the inclusion criteria for intensive blood pressure lowering to treat intracerebral haemorrhage
Spontaneous haemorrhage, within 6 hours of symptom onset, blood pressure 150-220mmHg
State the exclusion criteria for intensive blood pressure lowering to treat intracerebral haemorrhage
Structural cause of haematoma, GCS 3-5, massive haematoma with poor prognosis, planned early surgery
Give a piece of evidence against using surgery to treat intracerebral haemorrhage
The STICH-II trial found surgery had only a minimal effect on outcome